Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Kiniksa Pharmaceuticals, Ltd. Banner

Kiniksa Pharmaceuticals, Ltd.

KNSA Stock Analysis

Page title

Section title

About Kiniksa Pharmaceuticals, Ltd.

Biotechnology
Healthcare

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide...

Kiniksa Pharmaceuticals, Ltd. Key Metrics

Market Cap
$2B
52 Weeks Low
$14.12
52 Weeks High
$27.92
P/B
4.12x
P/E
-175.39x
P/S
5.31x

Upcoming Events

    KNSA Analyst Forecasts

    ‌
    ‌

    KNSA Financials

    KNSA Income Statement Key Metrics

    • Revenue(TTM)338.93 M
    • Gross Profit(TTM)211.78 M
    • EBITDA(TTM)-26.37 M
    • Net Income(TTM)-10.23 M
    • EPS Diluted(TTM)-0.15500000000000003

    Decode KNSA's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    KNSA earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of KNSA (0.663) is higher than the average of its peers (0.195).

    Net Profit Margin vs Peers

    Net profit margin ratio of KNSA (0.052) is higher than the average of its peers (-18.520).

    KNSA Return on Equity

    See how efficiently KNSA generates profit for it's shareholders.

    3.21%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of KNSA (0.032) is higher than the average of its peers (-0.364).

    Return on Equity Growth

    KNSA's Return on Equity has shown poor growth over the past 10 years, increasing by only -34.36%.

    KNSA Revenue Growth

    See how KNSA has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    KNSA's revenue has grown significantly over the past 10 years, increasing by over 0%.